Episode 18: Karen Petrou and David Brint - BioBonds

Episode 18 • March 23, 2022 • 00:55:46
Episode 18: Karen Petrou and David Brint - BioBonds
Few & Far Between: How Biotech Gets Built
Episode 18: Karen Petrou and David Brint - BioBonds

Mar 23 2022 | 00:55:46

/

Show Notes

On this week’s Few & Far Between podcast episode, Biorasi’s CEO, Chris O'Brien, welcomes Karen Petrou and David Brint for an in-depth discussion on BioBonds and how they can jumpstart funding in clinical research for rare disease and other disorders.

Other Episodes

Episode 55

July 09, 2025 • 00:38:46
Episode Cover

Episode 55: Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess®

How much do you know about clinical trials in Latin America? Take a deep dive with us as we explore the benefits and risks...

Listen

Episode 23

September 14, 2022 • 00:37:26
Episode Cover

Episode 23: Dr. Arun Bhatt, Consultant for Clinical Research and Drug Development in India

What makes India a smart and viable setting for today’s clinical trials? Join us for the latest episode of Few & Far Between. Biorasi's ...

Listen

Episode 0

May 12, 2021 • 00:02:29
Episode Cover

Episode 0: Welcome to the Few & Far Between Podcast

Welcome to Few & Far Between: Conversations About Rare Disease Research with your host, Chris O'Brien. Episode Zero contains everything you need to know...

Listen